Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

HIV Viral Non-Suppression and Its Associated Factors Among PMTCT Mothers Receiving ARV Treatment in Ethiopia

View through CrossRef
AbstractBackgroundPediatric HIV infection is mainly caused by Mother-to-child transmission (MTCT). Without any effective medical intervention, 15-45% of infants born to HIV-positive women will become infected with HIV. The contribution of viral non-suppression for MTCT is high. Hence, this study was to determine the magnitude of HIV viral non-suppression, and associated factors among PMTCT Mothers in Ethiopia.MethodsThe study was conducted from April 1, 2023, to December 31/ 2024 at 16 public health facilities. An institutional-based cross-sectional study was employed and 496 HIV-positive pregnant and lactating women on ART were included. Data was collected using a prechecked questionnaire with paper mode and ODK (Open Data Kit) for each participant. Venous blood was collected using two Ethylenediamine Tetra acetic Acid (EDTA) tubes for HIV viral load, CD4 and Hgb test. HIV viral load tests were conducted at the EPHI (Ethiopian Public Health Institute) National HIV reference laboratory using the COBAS 4800 System (Roche Molecular Diagnostics). Data was edited and exported to SPSS from the ODK data file, and finally data analysis was performed using SPSS version 26 software.Results496 PMTCT Mothers were included in this study, the prevalence of HIV viral non-suppression was 2.2% (95% CI; 1.1-3.9), the rate of viral detectability was 21.8 % (95% CI; 18.2-25.7) and the rate of low-level viremia (LLV) was 9.1%. Family size (X2=7.20; p<0.001), a poor and fair level of Adherence (X2=18.553; p<0.001), exposure to opportunistic infection (X2=25.29; p<0.001), survey time WHO clinical stages II & III (X2=25.29; p<0.001), HIV status non-disclosure other than Health care workers (HCWs) (X2=4.408; p=0.036), and low survey time CD4 count (<350 cells/ul) ( X2= 15.989; p<0.001) were significantly associated to the rate of HIV viral non-suppression.ConclusionsIn this study, HIV viral non-suppression among pregnant and lactating women is relatively low (meet the UNAIDS 2030 target). However, Family size, level of Adherence, exposure to opportunistic infection, WHO clinical stage level II and III, HIV status disclosure and low CD4 count were significantly associated with the prevalence of viral non-suppression. To achieve persistent HIV viral suppression enhanced adherence and counselling services should be provided, tailored to the needs of the specific target group.
Title: HIV Viral Non-Suppression and Its Associated Factors Among PMTCT Mothers Receiving ARV Treatment in Ethiopia
Description:
AbstractBackgroundPediatric HIV infection is mainly caused by Mother-to-child transmission (MTCT).
Without any effective medical intervention, 15-45% of infants born to HIV-positive women will become infected with HIV.
The contribution of viral non-suppression for MTCT is high.
Hence, this study was to determine the magnitude of HIV viral non-suppression, and associated factors among PMTCT Mothers in Ethiopia.
MethodsThe study was conducted from April 1, 2023, to December 31/ 2024 at 16 public health facilities.
An institutional-based cross-sectional study was employed and 496 HIV-positive pregnant and lactating women on ART were included.
Data was collected using a prechecked questionnaire with paper mode and ODK (Open Data Kit) for each participant.
Venous blood was collected using two Ethylenediamine Tetra acetic Acid (EDTA) tubes for HIV viral load, CD4 and Hgb test.
HIV viral load tests were conducted at the EPHI (Ethiopian Public Health Institute) National HIV reference laboratory using the COBAS 4800 System (Roche Molecular Diagnostics).
Data was edited and exported to SPSS from the ODK data file, and finally data analysis was performed using SPSS version 26 software.
Results496 PMTCT Mothers were included in this study, the prevalence of HIV viral non-suppression was 2.
2% (95% CI; 1.
1-3.
9), the rate of viral detectability was 21.
8 % (95% CI; 18.
2-25.
7) and the rate of low-level viremia (LLV) was 9.
1%.
Family size (X2=7.
20; p<0.
001), a poor and fair level of Adherence (X2=18.
553; p<0.
001), exposure to opportunistic infection (X2=25.
29; p<0.
001), survey time WHO clinical stages II & III (X2=25.
29; p<0.
001), HIV status non-disclosure other than Health care workers (HCWs) (X2=4.
408; p=0.
036), and low survey time CD4 count (<350 cells/ul) ( X2= 15.
989; p<0.
001) were significantly associated to the rate of HIV viral non-suppression.
ConclusionsIn this study, HIV viral non-suppression among pregnant and lactating women is relatively low (meet the UNAIDS 2030 target).
However, Family size, level of Adherence, exposure to opportunistic infection, WHO clinical stage level II and III, HIV status disclosure and low CD4 count were significantly associated with the prevalence of viral non-suppression.
To achieve persistent HIV viral suppression enhanced adherence and counselling services should be provided, tailored to the needs of the specific target group.

Related Results

Faktor Prediktor Kegagalan Virologis pada Pasien HIV yang Mendapat Terapi ARV Lini Pertama dengan Kepatuhan Berobat Baik
Faktor Prediktor Kegagalan Virologis pada Pasien HIV yang Mendapat Terapi ARV Lini Pertama dengan Kepatuhan Berobat Baik
Pendahuluan. Pada negara dengan keterbatasan sumber daya, pengukuran viral load (VL) sebagai prediktor efektivitas terapi antiretroviral (ARV) tidak selalu mudah untuk diakses oleh...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Stigma Kills
Stigma Kills
Stigma due to an HIV diagnosis is a well-known phenomenon and is a major barrier to accessing care.1Over the last forty years, HIV has been transformed from a fatal disease to a ma...
Cholesterol 25-hydroxylase suppresses avian reovirus replication by its enzymatic product 25-hydroxycholesterol
Cholesterol 25-hydroxylase suppresses avian reovirus replication by its enzymatic product 25-hydroxycholesterol
Avian reovirus (ARV) causing viral arthritis/tenosynovitis and viral enteritis in domestic fowl has significantly threatened on the poultry industry worldwide. ARV is a non-envelop...

Back to Top